News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
202 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (202)
2 (163)
3 (150)
4 (1)
6 (113)
7 (192)
8 (195)
9 (146)
10 (94)
11 (1)
12 (5)
13 (183)
14 (272)
15 (209)
16 (183)
17 (86)
18 (3)
19 (5)
20 (142)
21 (207)
22 (173)
23 (165)
24 (67)
25 (3)
26 (3)
27 (139)
28 (227)
29 (177)
30 (210)
31 (85)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Medtronic Announces Paurvi Bhatt as President of Medtronic Foundation
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced Paurvi Bhatt as the new President of the Medtronic Foundation and Vice President of Medtronic Philanthropy.
August 1, 2018
·
2 min read
BioForest
VisCardia Announces First Implant of the VisONE® System for Treating Heart Failure
VisCardia Inc. announced today the first implant of the VisONE® implantable system for heart failure, and the commencement of its VisONE Heart Failure pilot study in Ukraine.
August 1, 2018
·
3 min read
Genetown
Blueprint Medicines to Present at Upcoming Investor Conferences in August 2018
Blueprint Medicines Corporation announced its participation in the following upcoming investor conferences:
August 1, 2018
·
1 min read
Business
Cologuard® revenue increased 78 percent to $103 million during second quarter
More than 10,000 healthcare providers ordered their initial Cologuard
August 1, 2018
·
12 min read
Business
Tocagen to Report Second Quarter 2018 Financial Results on Tuesday, August 7
Tocagen Inc. announced it will report its second quarter 2018 financial results and business progress on Tuesday, August 7, 2018, after the close of the U.S. financial markets.
August 1, 2018
·
1 min read
Business
Vanda Pharmaceuticals Reports Second Quarter 2018 Financial Results
Total net product sales were $47.4 million in the second quarter of 2018
August 1, 2018
·
25 min read
Business
DURECT Corporation Announces Second Quarter 2018 Financial Results and Provides Corporate Update
Live Webcast of Earnings Call Today at 4:30 p.m. Eastern Time
August 1, 2018
·
18 min read
Biotech Bay
Arcus Biosciences to Participate in the 2018 Wedbush PacGrow Healthcare Conference
Arcus Biosciences, Inc. will participate in a fireside chat at the 2018 Wedbush PacGrow Healthcare Conference on Tuesday, August 14, 2018 at 2:30 pm ET at the Parker New York, in New York City, NY.
August 1, 2018
·
1 min read
Biotech Beach
DexCom Reports Second Quarter 2018 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2018.
August 1, 2018
·
9 min read
Business
Masimo Reports Second Quarter 2018 Financial Results and Announces Board Authorization of a New Stock Repurchase Program
Total revenue, including royalty and other revenue, was $211.6 million
August 1, 2018
·
25 min read
Previous
18 of 21
Next